Platelet activation in subjects with subclinical hypothyroidism

Medical Science Monitor

Volumn 13, Issue 4, 2007, Pages

  Coban, Erkan ^a   Yazicioglu, Gokhan ^a   Ozdogan, Mustafa ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Cardiovascular risk; Mean platelet volume; Platelet activation; Subclinical hypothyroidism

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID PEROXIDASE ANTIBODY; THYROXINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPOTHYROIDISM; MALE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPOTHYROIDISM; IMMUNOASSAY; MALE; PLATELET ACTIVATION; PLATELET COUNT;

EID: 34147095846     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Michalopoulu G, Alevizaki M, Piperingos G et al: High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol, 1998; 138: 141-45
2. Fowler PB: The thyroid, blood flow and atheroma. QJM, 2000; 93: 477-85
3. Cappola AR, Ladenson PW: Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab, 2003; 88: 2438-44
4. Vanderpump MP, Tunbridge WN, French JM et al: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf), 1995; 43: 55-68
5. Sawin CT, Castelli WP, Hershman JM et al: The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med, 1985; 145: 1386-88
6. Akbar DH, Ahmed MM, Hijazi NA: Subclinical hypothyroidism in elderly women attending an outpatient clinic. Med Sci Monit, 2004; 10(5): CR229-32
7. Foldes J, Banos C, Winkler G: Subclinical hypothyroidism and arteriosclerosis. Orv Hetil, 2004; 145: 1601-7
8. Gaspar IA: Postmortem observations on the thyroid in atherosclerosis. J Am Geriatr Soc, 1968; 16: 686-95
9. Becker C: Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev, 1985; 6: 432-40
10. Hamano K, Inoune I: Increased risk for atherosclerosis estimated by pulse wave velocity in hypothyroidism and its reversal with appropriate thyroxine treatment. Endocr J, 2005; 52: 95-101
11. Kwetny C, Heldgaard PE, Bladbjerg EM, Gram J: Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf), 2004; 61: 232-38
12. Deicher R, Vierhapper H: Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid, 2002; 12: 733-36
13. Kung AW, Pang RW, Janus ED: Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol (Oxf), 1995; 43: 445-49
14. Guldiken S, Demir M, Turgut B et al: Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocr J, 2005; 52: 363-67
15. Hak AE, Pols HA, Visser TJ et al: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med, 2000; 132: 270-78
16. Ladenson PW, Wilson MC, Gardin J et al: Relationship of subclinical hypothyroidism to cardiovascular risk factors and disease in an elderly population. Thyroid, 1994; 4: S-18
17. Tunbridge WM, Evered DC, Hall R et al: Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf), 1977; 7: 495-508
18. Benzaquen LR, Yu H, Rifai N: High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment. Crit Rev Clin Laboratory Sci, 2002; 39: 459-97
19. Monsalve MV, Thommasen HV, Pachev G, Frohlich J: Differences in cardiovascular risks in the aboriginal and non-aboriginal people living in Bella Coola, British Columbia. Med Sci Monit, 2005; 11(1): CR21-28
20. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP: Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost, 2003; 9: 177-90
21. Broadley AJ, Gapper P, Schmitt M, Frenneaux MP: Supine rest reduces platelet activation and aggregation. Platelets, 2003; 14: 3-7
22. Allen RD, Zacharski LR, Widirstky ST et al: Transformation and motility of human platelets: details of the shape change and release reaction observed by optical and electron microscopy. J Cell Biol, 1979; 83: 126-42
23. Greisenegger S, Endler G, Hsieh K et al: Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke, 2004; 35: 1688-91
24. Endler G, Klimesch A, Sunder-Plassmann H et al: Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol, 2002; 117: 399-404
25. Kilicli Camur N, Demirtunc R, Konuralp C et al: Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit, 2005; 11(8): CR387-92
26. Martin JF, Bath PM, Burr ML: Influence of platelet size on outcome after myocardial infarction. Lancet, 1991; 338: 1409-11
27. Tschoepe D, Esser J, Schwippert B et al: Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost, 1991; 17: 433-39
28. Bath PM, Butterworth RJ: Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis, 1996; 7: 157-61
29. Kario K, Matsuo T, Nakao K: Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol, 1992; 14: 281-87
30. Bath PM, Missouris CG, Buckenham T, MacGregor GA: Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clin Sci (Lond), 1994; 87: 253-57
31. Bath PM: The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost, 1993; 70: 687-90
32. van Doormaal JJ, van der Meer J, Oosten HR et al: Hypothyroidism leads to more small-sized platelets in circulation Thromb Haemost, 1987; 58: 964-65
33. Ford HC, Carter JM: Moderate, chronic hypothyroidism does not lead to more small-sized platelets in the circulation. Thromb Haemost, 1988; 60: 524
34. Wu KK: Platelet activation and carotid arterial atherothrombosis. In: Gotto AM, Lenfant C, Paoletti R et al eds. Multiple Risk Factors in Cardiovascular Disease. Dordrecht, Netherlands: Kluwer Academic Publisher, 1998: 61-65
35. Kristensen SD: The platelet-vessel wall interaction in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoiesis. Dan Med Bull, 1992; 39: 110-27
36. van der Loo B, Martin JF: Megakaryocytes and platelets in vascular disease. Baillieres Clin Haematol, 1997; 10: 109-23
37. Wynn RF, Davies SV, Williams K, Trevett DG: The effects of time from venepuncture and choice of anticoagulant on mean platelet volume estimations. Clin Lab Haematol, 1995; 17: 173-76
38. Trowbridge EA, Reardon DM, Hutchinson D, Pickering C: The routine measurement of platelet volume: a comparison of light-scattering and aperture-impedance technologies. Clin Phys Physiol Meas, 1985; 6: 221-38